Patrick Cox has lived deep inside the world of transformative technologies for over 25 years. In the 1980s, he worked in computer software development and manufacturing. By the mid-1990s, he worked as a consultant for Netscape — the company that handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured Patrick's research numerous times. He's also appeared on Crossfire and Nightline. Patrick has been quoted by The Wall Street Journal and Reason magazine. His expertise brought him to Agora Financial, where he now heads Breakthrough Technology Alert, the only place you'll find the truly transformational technologies that offer exponential gains.
One of the most naive idioms of all time is that the world will beat a path to your door if you build a better mousetrap. In fact, you’re more likely to be charged with endangering some previously unknown subspecies of rodentia.
Readers of my Breakthrough Technology Alert letter know that ...read more
American journalism (like the journalism of any other country) is predominantly paltry and worthless. Its pretensions are enormous, but its achievements are insignificant. — H.L. Mencken
Last week, an article by Rob Stein appeared in The Washington Post titled “Scientists Report Possibly Crucial Advance in Human Embryonic Stem Cell Research.” Stein, ...read more
Biotechnology, nanotechnology and semiconductors are all areas investors watch closely for the next great new tech. However, transformational technology investment opportunities aren’t always found in what are commonly regarded as breakthrough technology fields.
Sometimes, breakthrough technologies quietly emerge in mature, well-established industries.
Today I want to introduce you to a transformational technology ...read more
A Bloomberg story about the meeting gleaned the following reasoning. “Productivity losses and medical treatment for cancer, diabetes and other noncontagious diseases will cost $47 trillion by 2030, according to the first study that quantifies the likely expense of leading causes of death.
The fascinating thing about the article as well ...read more
I want to tell you a story. I’m going to give you a little bit of back story, a couple of threads about this. This CEO accidentally ended up owning a tobacco curing business. He didn’t like the tobacco company very much. All his family had worked in tobacco; he’d ...read more
I didn’t initially recognize the name but as soon as he began talking about himself, it all came together. I remember when he invented the tobacco curing technology that dramatically reduces carcinogenic toxins. He financed that research with a small part of the fortune he had made as a major ...read more
The science story with the biggest buzz recently was probably the successful treatment of three leukemia patients by scientists from the University of Pennsylvania.
Frankly, I find this absurd… given much bigger stories out there.
Nevertheless, the results of the leukemia treatment were extremely interesting. I'm going to talk about them today, ...read more
Last year in at the Agora Financial Investment Symposium I predicted that this would be a very big year.
I’ve been saying for a while that scientific progress is moving so fast that most people are unable to deal with the kinds of breakthroughs that are happening.
I’m even astonished.
I didn’t think ...read more
In all my years of research, I have never seen such an era of innovation and breakthroughs in the medical field as we are witnessing today…
Today we are seeing more and more small biotech companies racing toward the next big breakthrough. To be on the forefront of technology in this ...read more
As I’ve said many times, the best way to get rich is simply to live longer and let the mathematics of exponential portfolio growth do its work. And— I have a company that has a synthesized form of a natural alkaloid I believe will allow you to do just that. ...read more
Penny stocks, options, and emerging market plays offer some of the best gain potential in the investment world. The Penny Sleuth features unbiased and independent analysis on penny stocks, OTCBB, options and more!
